Available until July 31, 2024 - Online CME Course

Breast cancer risk assessment entails understanding clinical and genomic risk factors. Available risk calculation models provide population level risk with limitations in implementation in clinical practice. We need to advance the paradigm and transition to precision prevention and personalized risk stratification. With accurate risk assessment clinicians can optimize clinical benefits including surveillance imaging and risk reducing medication options. New research on the use of single nucleotide polymorphisms and polygenic risk score could be useful for stratifying and predicting individualized breast cancer risk and enhance shard decision making opportunities in management of women at increased risk for breast cancer

Available until February 28, 2026 - Online CME Course

A symposium delivered entirely by women of national and international recognition in the fields of gastroenterology and hepatology. This symposium highlights a spectrum of topics including, clinical care, education, clinical-basic science research and professional development knowledge.

March 20 - 23, 2024 - JW Marriott Scottsdale Camelback Inn Resort & Spa - Scottsdale, Arizona

This course offers Live (in-person) and Livestream (virtual) attendance options

This course is designed to update physicians, nurse practitioners, physician assistants and other healthcare providers practicing clinical gastroenterology and hepatology about new approaches to the diagnosis and management of gastrointestinal and liver diseases. Faculty present data on multiple topics including general gastroenterology, inflammatory bowel disease, colorectal neoplasia, esophageal diseases, motility, nutrition, pancreaticobiliary disorders, endoscopy and hepatology.

October 11 - December 12, 2023

This course is only available to Mayo Clinic Personnel

This course will only be offered via livestream.

Mayo Clinic Project ECHO™ (Extension for Community Healthcare Outcomes) seeks to be a force multiplier to share academic clinical knowledge with health care providers who practice in rural and underserved areas and want to increase their knowledge of how to identify and treat liver disease. During regularly scheduled ECHO sessions, via Zoom, participants will learn to assess and risk-stratify patients to identify liver disease. Interactive didactics will be presented in the context of “All Teach. All Learn.” CME credit will be awarded to participants, at no cost. Through the ECHO model, local providers are trained by academic specialists. As a result of this training higher quality healthcare will be delivered locally, disease progression is arrested, steps are made toward health equity in marginalized demographics, and population health outcomes are improved. The aim of Mayo Clinic Project ECHO is to effectively improve the capacity of clinicians treating liver disease throughout Mayo Clinic Health System to improve patient outcomes. The project is a collaborative model of medical education and care management that helps providers deliver care to patients with chronic liver disease. The project strives to narrow gaps in healthcare disparities for unrepresented minority populations and reduce the burden on the patients by allowing improved access to specialty care. Why is ECHO Important? Prevalence of Liver Disease Liver disease is a significant health concern that is often silent. It is estimated that 35% of the US population suffers from silent liver disease. Liver disease encompasses a range of conditions that affect the liver’s function and structure, including steatotic liver disease (previously known as fatty liver), alcoholic liver disease, viral hepatitis, cirrhosis, liver cancer, and more. If liver disease is diagnosed and addressed early, the consequences can be mitigated, and patient outcomes are much improved.

Available until February 28, 2027 - Online CME Course

Video capsule endoscopy (VCE) is currently considered the gold standard in the investigation of small bowel disease and is widely available in clinical practice as a noninvasive modality to examine the small bowel. This course provides a structured VCE training curriculum with a validated assessment tool for gastroenterologists and trainees and includes four hours of didactic tutoring, hardware and software instruction, and review of cases with VCE experts. Participants are then expected to complete 25 VCE interpretations. A formalized and validated assessment tool was developed and referred to as the capsule competency test (CapCT). This test evaluates the fundamentals of knowledge for the procedure including indications and contraindications, and the ability to accurately identify, interpret, and document VCE findings. Participants are required to complete the CapCT as part of their training.

September 5 - 8, 2024 - Radisson Blu Aqua Hotel Chicago - Chicago, Illinois

This course offers Live (in-person) and Livestream (virtual) attendance options

The Mayo Clinic Gastroenterology and Hepatology Board Review is a high-yield program designed to prepare candidates for the American Board of Internal Medicine (ABIM) initial and maintenance of certification examinations in gastroenterology and hepatology. Case-based content delivered by Mayo Clinic faculty provides learners with the most time-efficient, comprehensive review to assist in successful preparation for the board exam. In addition, attendees receive up-to-date, practical information that can be applied immediately into daily clinical practice.